Adma Biologics paid its 4 named executives $18.8M in total in FY2025 (Dec). CEO Adam S. Grossman was paid $10.2M of that.
Pay$100 in the stock at the end of FY21 → $1.3K
Pay of each named executive
Adam S. GrossmanPresident, Chief Executive Officer and Director
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Kaitlin KestenbergChief Operating Officer & Senior Vice President, Compliance
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Brad L. TadeFormer Executive Vice President and Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed |
4 years
Paul Terence Kohler, Jr.Current Chief Financial Officer and Treasurer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | Not disclosed | ||||||
| FY2023 (Dec) | Not disclosed |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 3 peers with pay on file was $23.2M. The CEO of Adma Biologics was paid $10.2M, 56% below the median.
- 1Exelixis
- 2Halozyme Therapeutics
- 3Adma BiologicsThis company
- 4Alkermes plc.
- 5ACADIA Pharmaceuticals Inc.Not disclosed
- 6ANI Pharmaceuticals, Inc.Not disclosed
- 7Amicus Therapeutics, Inc.Not disclosed
- 8Amphastar Pharmaceuticals, Inc.Not disclosed
- 9Apellis Pharmaceuticals, Inc.Not disclosed
- 10Catalyst Pharmaceuticals, Inc.Not disclosed
- 11Collegium Pharmaceutical, Inc.Not disclosed
- 12Corcept TherapeuticsNot disclosed
- 13Evolus, Inc.Not disclosed
- 14Harmony Biosciences Holdings, Inc.Not disclosed
- 15Intra-Cellular Therapies, Inc.Not disclosed
- 16MannKind CorporationNot disclosed
- 17MiMedx Group, Inc.Not disclosed
- 18Mirum Pharmaceuticals, Inc.Not disclosed
- 19Sarepta Therapeutics, Inc.Not disclosed
- 20Supernus Pharmaceuticals, Inc.Not disclosed
- 21TG Therapeutics, Inc.Not disclosed
- 22Vericel CorporationNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.